Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment

Photo for illustrative purposes only. Photo by National Cancer Institute / Unsplash

Subscribe to our Telegram channel to get a daily dose of business and lifestyle news […]